Incyte (INCY) EBT Margin (2010 - 2026)

Incyte (INCY) posted EBT Margin of 27.0% for Q1 2026, up 4.33% on a QoQ basis from 25.88% in Q4 2025, and up 476.0% year-over-year from 4.69% in Q1 2025.

Incyte (INCY) EBT Margin (2010 - 2026) Analysis & Trends

Incyte's EBT Margin history runs 17 years deep, the most recent figure standing at 27.0% for Q1 2026.

  • Quarterly EBT Margin rose 476.0% year-over-year to 27.0% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 33.09% (up 2596.0% YoY) and the FY2025 annual result came in at 32.37%, up 2491.0% from the prior year.
  • EBT Margin was 27.0% for Q1 2026 at Incyte, up from 25.88% in the prior quarter.
  • Across five years, EBT Margin topped out at 45.91% in Q2 2025 and bottomed at 37.34% in Q2 2024.
  • A 5-year average of 19.73% and a median of 25.44% in 2023 frame the typical range for EBT Margin.
  • Annual changes were most pronounced in 2024 — EBT Margin slumped 6642 bps — and 2025, when it soared 8325 bps.
  • Incyte's EBT Margin stood at 8.7% in 2022, then surged by 207 bps to 26.74% in 2023, then dropped by 0 bps to 26.62% in 2024, then fell by 3 bps to 25.88% in 2025, then increased by 4 bps to 27.0% in 2026.
  • Business Quant data shows INCY's EBT Margin at 27.0% in Q1 2026, 25.88% in Q4 2025, and 35.31% in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBT Margin (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 17.13%
4 NuCana 279.75 Bn 279.75 Bn - -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 41.95%
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 23.05%
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn 34.77%
9 Revolution Medicines 37.78 Bn 37.78 Bn - -
10 Incyte 23.33 Bn 19.32 Bn 1.17 Bn 27.00%

Historic Data

Download Data
DateValue
Mar 31, 2026 27.00%
Dec 31, 2025 25.88%
Sep 30, 2025 35.31%
Jun 30, 2025 45.91%
Mar 31, 2025 22.24%
Dec 31, 2024 26.62%
Sep 30, 2024 13.76%
Jun 30, 2024 -37.34%
Mar 31, 2024 26.81%
Dec 31, 2023 26.74%
Sep 30, 2023 25.44%
Jun 30, 2023 29.08%
Mar 31, 2023 6.41%
Dec 31, 2022 8.70%
Sep 30, 2022 18.05%
Jun 30, 2022 25.17%
Mar 31, 2022 9.62%
Dec 31, 2021 13.91%
Sep 30, 2021 25.77%
Jun 30, 2021 24.32%